Resistance analysis of hepatitis C virus genotype 1 prior treatment null responders receiving daclatasvir and asunaprevir
Author:
Affiliation:
1. Research and Development; Bristol-Myers Squibb; Wallingford; CT
2. Research and Development; Bristol-Myers Squibb; Hopewell; NJ
Publisher
Wiley
Subject
Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.26388/fullpdf
Reference24 articles.
1. Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect;Gao;Nature,2010
2. Preclinical profile and characterization of the hepatitis C virus NS3 protease inhibitor asunaprevir (BMS-650032);McPhee;Antimicrob Agents Chemother,2012
3. Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial;Pol;Lancet Infect Dis,2012
4. Pol S Ghalib R Rustgi V Martorell C Everson GT Tatum HA High rates of SVR24 for BMS-790052, a NS5A replication complex inhibitor, in combination with peg-IFNa-2a and ribavirin (RBV): phase 2a trial in treatment-naïve HCV-genotype 1 subjects 2011 H1 376
5. 1195 BMS-650032, an NS3 inhibitor, in combination with peginterferon alpha-2a and ribavirin in treatment-naive subjects with genotype 1 chronic hepatitis c infection;Bronowicki;J Hepatol,2011
Cited by 113 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Hepatitis C Virus Genotype 5 Variability in Treatment-Naïve Patients in South Africa;Intervirology;2023
2. Real-World Therapeutic Outcomes of Direct-Acting Antiviral Regimens and Formidable Challenges;Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives;2023-01
3. The Role of RASs /RVs in the Current Management of HCV;Viruses;2021-10-18
4. Molecular docking and dynamics simulations reveal the potential of anti-HCV drugs to inhibit COVID-19 main protease;Pharmaceutical Sciences;2021-01-29
5. Molecular characterization of hepatitis C virus for subtype determination and resistance-associated substitutions detection among Chinese voluntary blood donors;Antiviral Research;2020-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3